首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1496877

全球血型分型市场 - 2024-2031

Global Blood Group Typing Market - 2024-2031

出版日期: 2024年06月18日 | 出版商:

DataM Intelligence | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

司机

需要输血的道路事故、紧急情况和创伤病例数量不断增加

全球血型分型市场的需求是由多种因素所驱动的。驱动因素之一是需要输血的道路事故、紧急情况和创伤病例数量的增加，这是血型定型市场的重要驱动力。

道路事故和外伤病例通常会导致严重伤害、失血性休克和慢性贫血，可能需要进行大手术。在这种情况下，输血对于确保患者的生存至关重要。

此外，该行业的主要参与者推出新产品和创新应用程式将推动该市场的成长。根据国家输血委员会 2024 年 6 月的消息，Transfusion 推出了新的输血培训中心，专门为所有从事输血工作的医疗保健专业人员以及任何希望增加输血知识的人提供教育和培训。

同样，2024 年 2 月，NHS 血液与移植局 (NHSBT) 发布了其首款创新虚拟实境培训应用程式“NHSBT 血液识别”，该应用程式真实地模拟了用于挽救生命的输血的血液测试过程。

此外，伙伴关係和协作等关键参与者策略将推动该市场的成长。例如，2023 年 3 月，Werfen 完成了对 Immucor, Inc. 的收购，扩大了在专业诊断领域的领导地位。透过此次合作，Werfen 扩大了其为医院和临床实验室提供的诊断解决方案组合。

血型定型产品的高成本、血型定型的复杂性、血液服务基础设施薄弱、缺乏意识和熟练的专业人员、严格的法规以及先进技术的获取有限等因素预计将阻碍市场的发展。

有关此报告的更多详细资讯 - 索取样品

Blood group typing can be classified as forward and reverse typing based on traditional serological testing. Specifically, forward typing involves the detection of A and B antigens based on RBC agglutination by the specific antiserum and the intensity of agglutination, whereas reverse typing is used to identify the presence or absence of anti-A, anti-B, and anti-AB antibodies in plasma or serum.

Market Dynamics

Drivers

Increasing Number of Road Accidents, Emergencies, & Trauma Cases Necessitating Blood Transfusions

The demand for the global blood group typing market is driven by multiple factors. One of the driving factors is the increasing number of road accidents, emergencies, and trauma cases requiring blood transfusions is a significant driver of the blood group typing market.

Road accidents and trauma cases often result in severe injuries, hemorrhagic shock, and chronic anemia, which may require major surgeries. In such situations, blood transfusions are crucial to ensure the patient's survival.

In addition, key players in the industry introducing new launches and innovative apps would drive this market growth. According to the National Blood Transfusion Committee in June 2024, Transfusion introduced the new Transfusion Training Hub, specifically designed to support education and training for all healthcare professionals working with Blood Transfusion and for anyone wishing to increase their transfusion knowledge.

Similarly in February 2024, NHS Blood and Transplant (NHSBT) released its' first innovative virtual reality training app 'NHSBT Blood Identification' which realistically simulates the process of testing blood for lifesaving blood transfusions.

Moreover, key players strategies such as partnerships and collaborations would drive this market growth. For instance, in March 2023, Werfen completed the acquisition of Immucor, Inc., expanding leadership in Specialized Diagnostics. By using this partnership, Werfen expands its portfolio of diagnostic solutions for hospitals and clinical laboratories.

Factors such as the high cost of blood group typing products, the complexity of blood group typing, poor blood services infrastructure, lack of awareness & skilled professionals, stringent regulations, and limited access to advanced technology are expected to hamper the market.

For more details on this report - Request for Sample

Segment Analysis

The global blood group typing market is segmented based on product, technique, test type, end-user, and region.

The ABO blood tests segment accounted for approximately 23.4% of the global blood group typing market share

The ABO blood tests segment is expected to hold the largest market share over the forecast period. The ABO system is defined by the presence or absence of the A and/or B antigens on human red blood cells and by the presence of antibodies in the plasma or serum corresponding to the antigen or antigens missing in the red blood cells.

Blood groups are usually an individual's combination of antigens on the surface of RBCs, typically of the ABO blood group system and the RH blood group system.

Moreover, key players in the industry introduce innovative technologies that would propel this market growth. For instance, in May 2024, Thermo Fisher Scientific, introduced the Applied Biosystems Axiom BloodGenomiX Array and Software, a first-of-its-kind solution for more precise blood genotyping in clinical research.

The new array covers more than 40 genes and 260 antigens across 38 blood group systems in a single, high-throughput assay. It also detects tissue (HLA) and platelet (HPA) types. Validation studies have demonstrated its accuracy, with a concordance rate of 99.89% with participants' blood group antigen types.

In addition, government initiatives and awareness camps are propelling this segment's growth. As per the Hindu Business Line news in June 2022, the Centre calls for setting up blood group testing camps at all health centers on World Blood Donor Day. Centre calls for setting up blood group testing camps at all health centers on World Blood Donor Day.

Also, in June 2022, in Tamil Nadu, the Directorate of Public Health and Preventive Medicine launched the "Know Your Blood Group" campaign in all PHCs in the state.

Geographical Analysis

North America accounted for approximately 45.4% of the global blood group typing market share

North America region is expected to hold the largest market share over the forecast period. An increase in the number of road accidents and the rising prevalence of chronic diseases are the major factors driving the growth of the market.

In this region, advanced healthcare structure, government awareness programs, and partnerships and collaborations would drive this market growth. For instance, in January 2024, Mayor Muriel Bowser and the District of Columbia Fire and EMS Department announced the Whole Blood Program, an initiative designed to support and train paramedics in performing pre-hospital blood transfusions in partnership with the American Red Cross.

The Whole Blood Program is designed to increase survival rates and clinical outcomes for patients suffering from traumatic injuries, hemorrhagic shock, or severe bleeding by decreasing the amount of time it takes to replace lost blood.

Furthermore, there is an increasing demand for blood transfusion in the United States driving the market growth. According to U.S. blood supply facts in 2024, every 2 seconds someone in the U.S. needs blood and or platelets. Approximately 29,000 units of red blood cells are needed every day in the U. S. Nearly 5,000 units of platelets and 6.500 units of plasma are needed daily in the U.S.

Nearly 16 million blood components are transfused each year in the U.S. Sickle cell disease affects 90,000 to 100,000 people in the U.S. About 1,000 babies are born with the disease each year. Sickle cell patients can require blood transfusions throughout their lives.

Market Segmentation

By Product

Consumables
Instruments
Services

By Technique

PCR-based Techniques
- Allele-specific PCR
- Real-time PCR
Assay-based Techniques
Microarray-based Techniques
Massively Parallel Sequencing

By Test Type

ABO Blood Tests
Antigen Typing
Antibody Screening
HLA Typing
Cross Matching Tests

By End User

Hospitals
Blood Banks
Clinical Laboratories
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Middle East and Africa

Competitive Landscape

The major global players in the blood group typing market include Bio-Rad Laboratories, Inc., Grifols, Thermo Fisher Scientific Inc., Agena Bioscience, Inc., Bag Diagnostics, Lorne Laboratories Limited, Tulip Diagnostics, DIALAB GmbH, Rapid Labs Limited, and Immucor, Inc, among others.

Key Developments

In May 2023, Bio-Rad Laboratories, Inc. announced the launch of the IH-500TM NEXT System, a fully automated system for ID cards. The IH-500 NEXT System not only reduces instrument downtime and increases laboratory productivity, but also provides the flexibility and freedom to use high-performing Bio-Rad Reagent Red Blood Cells (RBCs), as well as the lab's RBCs or third-party Reagent RBCs.
In March 2022, Quotient Limited announced the receipt of the CE mark for the extended immunohematology microarray. The CE marking confirms the extended IH microarray meets the requirements of the European Medical Devices directive. The Company's MosaiQ platform offers an all-in-one, fully automated, high-performance solution in blood-testing laboratories and other settings.
In September 2022, Scientists from NHS Blood and Transplant (NHSBT) and the University of Bristol discovered a new blood group system, called Er, solving a 30-year-old mystery. The team investigated three known blood group antigens - molecules on the surface of red blood cells that can trigger an attack by the immune system - which did not fit into any known blood group system.

Why Purchase the Report?

To visualize the global blood group typing market segmentation based on product, technique, test type, end-user, and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development
Excel data sheet with numerous data points of global blood group typing market level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping is available in excel consisting of key products of all the major players.

The global blood group typing market report would provide approximately 70 tables, 68 figures, and 183 Pages.

Target Audience 2024

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product
3.2. Snippet by Technique
3.3. Snippet by Test Type
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Number of Road Accidents, Emergencies, & Trauma Cases Necessitating Blood Transfusions
  - 4.1.1.2. Increasing Demand for Blood Group Typing in Prenatal Testing
  - 4.1.1.3. Rising Number of Blood Donations
- 4.1.2. Restraints
  - 4.1.2.1. The High Cost of Blood Group Typing Products
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 7.1.2. Market Attractiveness Index, By Product
7.2. Consumables *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Instruments
7.4. Services

8. By Technique

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
- 8.1.2. Market Attractiveness Index, By Technique
8.2. PCR-based Techniques *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Allele-specific PCR
8.4. Real-time PCR
8.5. Assay-based Techniques
8.6. Microarray-based Techniques
8.7. Massively Parallel Sequencing

9. By Test Type

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 9.1.2. Market Attractiveness Index, By Test Type
9.2. ABO Blood Tests *
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Antigen Typing
9.4. Antibody Screening
9.5. HLA Typing
9.6. Cross Matching Tests

10. By End-User

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals *
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Ambulatory Surgical Centers
10.4. Blood Banks
10.5. Clinical Laboratories
10.6. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1. U.S.
  - 11.2.7.2. Canada
  - 11.2.7.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. UK
  - 11.3.7.3. France
  - 11.3.7.4. Italy
  - 11.3.7.5. Spain
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan
  - 11.5.7.4. South Korea
  - 11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. Bio-Rad Laboratories, Inc *
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio & Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Grifols
13.3. Thermo Fisher Scientific Inc
13.4. Agena Bioscience, Inc
13.5. Bag Diagnostics
13.6. Lorne Laboratories Limited
13.7. Tulip Diagnostics
13.8. DIALAB GmbH
13.9. Rapid Labs Limited
13.10. Immucor, Inc

LIST NOT EXHAUSTIVE